Yoshimi Iwanuma

Evaluation and Optimization of Different Cationic Liposome Formulations forin VivoGene Transfer

Nejat K. Egilmez, Yoshimi Iwanuma, Richard B. Bankert · Biochemical and Biophysical Research Communications · 1996 · 73 citations

Cell-based Drug Delivery, Nanomedicine, Lipid Preparation +6

Cytokine immunotherapy of cancer with controlled release biodegradable microspheres in a human tumor xenograft/SCID mouse model

Nejat K. Egilmez, Yong S. Jong, Yoshimi Iwanuma et al. · Cancer Immunology Immunotherapy · 1998 · 61 citations · Full text

Cytokine Immunotherapy, Nanomedicine, Cell-based Drug Delivery +9

Antitumor immune response of human peripheral blood lymphocytes coengrafted with tumor into severe combined immunodeficient mice.

Yoshimi Iwanuma, Fang-An Chen, Nejat K. Egilmez et al. · PubMed · 1997 · 46 citations

Cell Therapy, Bolus Injections, Immunology +18

Monoclonal antibody to HER-2/neu receptor enhances radiosensitivity of esophageal cancer cell lines expressing HER-2/neu oncoprotein

Shinsuke Sato, Yoshiaki Kajiyama, Masahiko Sugano et al. · International Journal of Radiation Oncology*Biology*Physics · 2004 · 42 citations

Her-2/neu Receptor, Oncology, Esophageal Cancer +8

Study of abnormal chromosome regions in esophageal squamous cell carcinoma by comparative genomic hybridization: relationship of lymph node metastasis and distant metastasis to selected abnormal regions

Noritaka Sakai, Yoshiaki Kajiyama, Yoshimi Iwanuma et al. · Diseases of the Esophagus · 2009 · 28 citations · Full text

Esophageal Cancer, Distant Metastasis, Genetics +16